Atlas Trials

Anti-Xa Levels in Critically Ill Patients Receiving Low-molecular-weight Heparin for Thromboprophylaxis in China

Clinical trial NCT03311984 · UNKNOWN

Trial details

NCT number
NCT03311984
Sponsor
Southeast University, China
Status
UNKNOWN
Study type
OBSERVATIONAL
Critically IllAnti-Xa
Start date
2017-08-15
Primary completion
2018-03-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.